Infection Control Today

Study Suggests Link Between Untreated Depression and Response to Shingles Vaccine

Results from a new study published in Clinical Infectious Diseases suggest a link between untreated depression in older adults and decreased effectiveness of the herpes zoster, or shingles, vaccine. Older adults are known to be at risk for shingles, a painful condition ...More

February 14, 2013

Posted in News

Shingles Vaccination is a Must, Says UB Microbiologist Who Knows From Experience

Terry D. Connell, PhD, knows a lot about the immune system: he’s a University at Buffalo professor in the Department of Microbiology and Immunology in the School of Medicine and Biomedical Sciences who conducts research on new vaccines for diseases, such as tuberculosis. ...More

February 7, 2013

Posted in News

No Increased Risk of Shingles Among RA Patients Who Receive the Shingles Vaccine

Although some have suggested that patients receiving medication for immune-mediated diseases such as rheumatoid arthritis or psoriasis may be at increased risk of herpes zoster (HZ; shingles) shortly after receipt of the vaccine, an analysis that included nearly 20,000 ...More

July 3, 2012

Posted in News

Short-Term Risk of Shingles Recurrence is Low

People who have had an episode of herpes zoster, also known as shingles, face a relatively low short-term risk of developing shingles, according to a Kaiser Permanente Southern California study published online in the Journal of Infectious Diseases. These findings suggest ...More

June 5, 2012

Posted in News

Kaiser Permanente Study Finds No Serious Reactions to Shingles Vaccine

The herpes zoster vaccine, also known as the shingles vaccine, is generally safe and well tolerated according to a Vaccine Safety Datalink study of 193,083 adults published online in the Journal of Internal Medicine. More than 1 million people develop shingles every year in ...More

April 23, 2012

Posted in News

Shingles Vaccine Doesn't Increase Risk in Taking Biologics for Autoimmune and Inflammatory Diseases

The live attenuated shingles (herpes zoster) vaccine (Zostavax®) does not appear to increase the short-term risk of developing shingles infection in people taking biologics for autoimmune and inflammatory diseases, according to research presented this week at the American ...More

November 7, 2011

Posted in News, Infections & Pathogens

Shingles May be Related to Elevated Risk of Multiple Sclerosis

Taiwanese investigators have found that there can be a significantly higher risk of multiple sclerosis (MS) occurring in the year following a shingles, or herpes zoster, attack. The findings, which support a long-held view on how MS may develop, are published in the Journal ...More

June 8, 2011

Posted in News

Study Challenges Concerns About Administering Pneumococcal and Shingles Vaccines Together

Administering both the pneumococcal and the herpes zoster vaccines to patients during the same visit is beneficial and does not appear to compromise the protective effect of the zoster vaccine, according to a Kaiser Permanente study published in the journal Vaccine. The ...More

May 16, 2011

Posted in News

UGA Compound Offers New Hope for Treatment of Adult Shingles

Researchers at the University of Georgia and Yale University have discovered a compound with the potential to be more effective than existing agents in treating the very painful blisters known as shingles—a condition that affects up to 30 percent of Americans, mostly ...More

April 21, 2011

Posted in News

FDA Approves Zostavax Vaccine to Prevent Shingles in Individuals Age 50-59

The Food and Drug Administration (FDA) today approved the use of Zostavax, a live attenuated virus vaccine, for the prevention of shingles in individuals 50 to 59 years of age. Zostavax is already approved for use in individuals 60 years of age and older. In the United ...More

March 25, 2011

Posted in News

ANTIMICROBIAL PRODUCTS	DISINFECTION/STERILIZA...
DISPOSABLE PRODUCTS	INFECTION CONTROL
LATEX-FREE PRODUCTS	More Options...

Shingles

Video Snapshot

Galleries

ICT Poll

Most Popular Articles

Buyer's Guide

Reports

Free Email Updates

featured links

First Name	Last Name
E-Mail